2:27:43 AM PST - Saturday, January 29th, 2022

KHN’s ‘What the Health?’: Dealing With Drug Prices  

By Editor - Thu Jan 13, 2:34 pm

  • Comments Off on KHN’s ‘What the Health?’: Dealing With Drug Prices

Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify , Apple Podcasts , Stitcher , Pocket Casts or wherever you listen to podcasts. Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer’s drug, to only patients participating in approved clinical trials. The FDA approved the drug in 2021 over objections of the agency’s outside advisers, who complained the evidence of Aduhelm’s efficacy is thin.

Go here to see the original:

KHN’s ‘What the Health?’: Dealing With Drug Prices

  • Comments Off on KHN’s ‘What the Health?’: Dealing With Drug Prices

Leave a Reply

Comments are closed on this post.